Literature DB >> 11420639

Transfection of urothelial cells using methyl-beta-cyclodextrin solubilized cholesterol and Dotap.

C Lawrencia1, R Mahendran, K Esuvaranathan.   

Abstract

the murine urothelial cell line, mb49 was transfected with the reporter gene pcmvlacz using a number of commercial transfection agents. the transfection efficiency of these agents, as determined by beta-galactosidase activity, is in the order of dotap>superfect>Fugene. The addition of methyl-beta-cyclodextrin solubilized cholesterol (MBC) to Dotap and Superfect further improved their transfection efficiency by 3.8-fold and 2.6-fold, respectively. beta-Galactosidase activity was detectable within 1 h of transfection and peaked at 48 h. Nuclear and cytoplasmic separation showed that with Dotap + methyl-beta-cyclodextrin solubilized cholesterol (DMBC), the DNA plasmid complex was found in both the nucleus and the cytoplasm. In vivo, murine bladders were transfected with an intravesical instillation of DMBC + DNA for 2 h. Two days later the bladder, lungs, liver, spleen and heart were assayed for the presence of the beta-galactosidase gene by staining and PCR. Expression of the gene was confined to the bladder. Both in vitro and in vivo expression was observed after as little as a 15 min exposure to DMBC:DNA. Expression of the marker gene was present up to 30 days after transfection in vivo. From our data it appears that DMBC is the best nonviral agent for the transfection of urothelial cells in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420639     DOI: 10.1038/sj.gt.3301462

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  6 in total

1.  Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells.

Authors:  Edmund Chiong; I-Ling Lee; Ali Dadbin; Anita L Sabichi; Loleta Harris; Diana Urbauer; David J McConkey; Rian J Dickstein; Tiewei Cheng; H Barton Grossman
Journal:  Clin Cancer Res       Date:  2011-03-17       Impact factor: 12.531

2.  Cyclodextrin-PEI-Tat Polymer as a Vector for Plasmid DNA Delivery to Placenta Mesenchymal Stem Cells.

Authors:  Wing-Fu Lai; Gu-Ping Tang; Xin Wang; Guo Li; Hong Yao; Zan Shen; Gang Lu; Wai Sang Poon; Hsiang-Fu Kung; Marie C M Lin
Journal:  Bionanoscience       Date:  2011-06-18

3.  In Vitro Gene Delivery Mediated by Asialofetuin-Appended Cationic Liposomes Associated with γ-Cyclodextrin into Hepatocytes.

Authors:  Keiichi Motoyama; Yoshihiro Nakashima; Yukihiko Aramaki; Fumitoshi Hirayama; Kaneto Uekama; Hidetoshi Arima
Journal:  J Drug Deliv       Date:  2010-12-09

4.  Tumor and microenvironment modification during progression of murine orthotopic bladder cancer.

Authors:  Sin Mun Tham; Kee Hui Ng; Sim Hwee Pook; Kesavan Esuvaranathan; Ratha Mahendran
Journal:  Clin Dev Immunol       Date:  2011-10-13

5.  Polyethylenimine600-β-cyclodextrin: a promising nanopolymer for nonviral gene delivery of primary mesenchymal stem cells.

Authors:  Haijun Tong; Chuandong Wang; Yan Huang; Qin Shi; Julio C Fernandes; Kerong Dai; Guping Tang; Xiaoling Zhang
Journal:  Int J Nanomedicine       Date:  2013-05-24

6.  A novel co-polymer based on hydroxypropyl alpha-cyclodextrin conjugated to low molecular weight polyethylenimine as an in vitro gene delivery vector.

Authors:  Hongliang Huang; Hai Yu; Da Li; Yang Liu; Fenping Shen; Jun Zhou; Qingqing Wang; Guping Tang
Journal:  Int J Mol Sci       Date:  2008-11-21       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.